Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?

Diabetes is one of the most common comorbidities in patients undergoing total knee arthroplasty (TKA) for osteoarthritis. However, the evidence remains unclear on how it affects patient-reported outcome measures after TKA. We reviewed prospectively collected data of 2840 patients who underwent prima...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of arthroplasty 2021-07, Vol.36 (7), p.2486-2491
Main Authors: Zhang, Siyuan, Chong, Mark, Lau, Bernard Puang Huh, Ng, Yau Hong, Wang, Xinyu, Chua, Weiliang
Format: Article
Language:English
Subjects:
diabetes
functional outcomes
patient-reported outcome measures
range of motion
total knee arthroplasty
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-1da7b5858e94a9587ed06fd08aa070974febb044ecb0f0d2efddf411470f9a543
cites cdi_FETCH-LOGICAL-c356t-1da7b5858e94a9587ed06fd08aa070974febb044ecb0f0d2efddf411470f9a543
container_end_page 2491
container_issue 7
container_start_page 2486
container_title The Journal of arthroplasty
container_volume 36
creator Zhang, Siyuan
Chong, Mark
Lau, Bernard Puang Huh
Ng, Yau Hong
Wang, Xinyu
Chua, Weiliang
description Diabetes is one of the most common comorbidities in patients undergoing total knee arthroplasty (TKA) for osteoarthritis. However, the evidence remains unclear on how it affects patient-reported outcome measures after TKA. We reviewed prospectively collected data of 2840 patients who underwent primary unilateral TKA between 2008 and 2018, of which 716 (25.2%) had diabetes. All patients had their HbA1c measured within 1 month before surgery, and only well-controlled diabetics (HbA1c
doi_str_mv 10.1016/j.arth.2021.02.070
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2506510848</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0883540321002308</els_id><sourcerecordid>2506510848</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-1da7b5858e94a9587ed06fd08aa070974febb044ecb0f0d2efddf411470f9a543</originalsourceid><addsrcrecordid>eNp9kE1LJDEURYOMjK3OH3AxZDmbKl-qkqo0DAyN3ygooswypCovmKaq0pOkG_z3pqfVpau3Ofdy3yHkhEHJgDWny1KH9FJWULESqhJa2CMzJuqqkByab2QGUtaF4FAfkMMYlwCMCcG_k4O6blvBGzkj07mnDzo5nFKkf116oedOd5gw0mu9QfrgfcBAb8ZV8Bsc_2Nu-ogUj7jyIaGh9-vU-zGnFjZl_sknPdDbCZEu8sbgV4OO6fXPMdm3eoj44_0ekefLi6ez6-Lu_urmbHFX9LVoUsGMbjshhcQ513MhWzTQWANS6_zlvOUWuw44x74DC6ZCa4zljPEW7FwLXh-RX7vePPvfGmNSo4s9DoOe0K-jqgQ0goHkMqPVDu2DjzGgVavgRh1eFQO19ayWautZbT0rqFRekEM_3_vX3YjmM_IhNgO_dwDmLzcOg4p9NtajcQH7pIx3X_W_ASM0j_s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506510848</pqid></control><display><type>article</type><title>Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?</title><source>ScienceDirect Freedom Collection</source><creator>Zhang, Siyuan ; Chong, Mark ; Lau, Bernard Puang Huh ; Ng, Yau Hong ; Wang, Xinyu ; Chua, Weiliang</creator><creatorcontrib>Zhang, Siyuan ; Chong, Mark ; Lau, Bernard Puang Huh ; Ng, Yau Hong ; Wang, Xinyu ; Chua, Weiliang</creatorcontrib><description><![CDATA[Diabetes is one of the most common comorbidities in patients undergoing total knee arthroplasty (TKA) for osteoarthritis. However, the evidence remains unclear on how it affects patient-reported outcome measures after TKA. We reviewed prospectively collected data of 2840 patients who underwent primary unilateral TKA between 2008 and 2018, of which 716 (25.2%) had diabetes. All patients had their HbA1c measured within 1 month before surgery, and only well-controlled diabetics (HbA1c <8.0%) were allowed to proceed with surgery. Patient demographics and comorbidities were recorded, and multiple regression was performed to evaluate the impact of diabetes on improvements in patient-reported outcome measures (Short Form 36 (SF-36), Western Ontario and McMaster University Osteoarthritis Index (WOMAC), Knee Society Score (KSS)) and knee range of motion (ROM). Compared with nondiabetics, patients with diabetes were more likely to possess a higher body mass index (P-value <.001), more comorbidities (P-value <.001), and poorer preoperative SF-36 Physical Component Summary (PCS) (P-value <.001), WOMAC (P-value = .002), KSS-function (P-value <.001), and knee ROM (P-value <.001). Multiple regression showed that diabetic patients experienced marginally poorer improvements in KSS-knee (−1.22 points, P-value = .025) and knee ROM (−1.67°, P-value = .013) than nondiabetics. However, there were no significant differences in improvements for SF-36 PCS (P-value = .163), Mental Component Summary (P-value = .954), WOMAC (P-value = .815), and KSS-function (P-value = .866). Patients with well-controlled diabetes (HbA1c <8.0%) can expect similar improvements in general health and osteoarthritis outcomes (SF-36 PCS and Mental Component Summary, WOMAC, and KSS-function) compared with nondiabetics after TKA. Despite having marginally poorer improvements in knee-specific outcomes (KSS-knee and knee ROM), these differences are unlikely to be clinically significant.]]></description><identifier>ISSN: 0883-5403</identifier><identifier>EISSN: 1532-8406</identifier><identifier>DOI: 10.1016/j.arth.2021.02.070</identifier><identifier>PMID: 33775468</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>diabetes ; functional outcomes ; patient-reported outcome measures ; range of motion ; total knee arthroplasty</subject><ispartof>The Journal of arthroplasty, 2021-07, Vol.36 (7), p.2486-2491</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-1da7b5858e94a9587ed06fd08aa070974febb044ecb0f0d2efddf411470f9a543</citedby><cites>FETCH-LOGICAL-c356t-1da7b5858e94a9587ed06fd08aa070974febb044ecb0f0d2efddf411470f9a543</cites><orcidid>0000-0002-7622-3388 ; 0000-0001-9648-0237</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33775468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Siyuan</creatorcontrib><creatorcontrib>Chong, Mark</creatorcontrib><creatorcontrib>Lau, Bernard Puang Huh</creatorcontrib><creatorcontrib>Ng, Yau Hong</creatorcontrib><creatorcontrib>Wang, Xinyu</creatorcontrib><creatorcontrib>Chua, Weiliang</creatorcontrib><title>Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?</title><title>The Journal of arthroplasty</title><addtitle>J Arthroplasty</addtitle><description><![CDATA[Diabetes is one of the most common comorbidities in patients undergoing total knee arthroplasty (TKA) for osteoarthritis. However, the evidence remains unclear on how it affects patient-reported outcome measures after TKA. We reviewed prospectively collected data of 2840 patients who underwent primary unilateral TKA between 2008 and 2018, of which 716 (25.2%) had diabetes. All patients had their HbA1c measured within 1 month before surgery, and only well-controlled diabetics (HbA1c <8.0%) were allowed to proceed with surgery. Patient demographics and comorbidities were recorded, and multiple regression was performed to evaluate the impact of diabetes on improvements in patient-reported outcome measures (Short Form 36 (SF-36), Western Ontario and McMaster University Osteoarthritis Index (WOMAC), Knee Society Score (KSS)) and knee range of motion (ROM). Compared with nondiabetics, patients with diabetes were more likely to possess a higher body mass index (P-value <.001), more comorbidities (P-value <.001), and poorer preoperative SF-36 Physical Component Summary (PCS) (P-value <.001), WOMAC (P-value = .002), KSS-function (P-value <.001), and knee ROM (P-value <.001). Multiple regression showed that diabetic patients experienced marginally poorer improvements in KSS-knee (−1.22 points, P-value = .025) and knee ROM (−1.67°, P-value = .013) than nondiabetics. However, there were no significant differences in improvements for SF-36 PCS (P-value = .163), Mental Component Summary (P-value = .954), WOMAC (P-value = .815), and KSS-function (P-value = .866). Patients with well-controlled diabetes (HbA1c <8.0%) can expect similar improvements in general health and osteoarthritis outcomes (SF-36 PCS and Mental Component Summary, WOMAC, and KSS-function) compared with nondiabetics after TKA. Despite having marginally poorer improvements in knee-specific outcomes (KSS-knee and knee ROM), these differences are unlikely to be clinically significant.]]></description><subject>diabetes</subject><subject>functional outcomes</subject><subject>patient-reported outcome measures</subject><subject>range of motion</subject><subject>total knee arthroplasty</subject><issn>0883-5403</issn><issn>1532-8406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LJDEURYOMjK3OH3AxZDmbKl-qkqo0DAyN3ygooswypCovmKaq0pOkG_z3pqfVpau3Ofdy3yHkhEHJgDWny1KH9FJWULESqhJa2CMzJuqqkByab2QGUtaF4FAfkMMYlwCMCcG_k4O6blvBGzkj07mnDzo5nFKkf116oedOd5gw0mu9QfrgfcBAb8ZV8Bsc_2Nu-ogUj7jyIaGh9-vU-zGnFjZl_sknPdDbCZEu8sbgV4OO6fXPMdm3eoj44_0ekefLi6ez6-Lu_urmbHFX9LVoUsGMbjshhcQ513MhWzTQWANS6_zlvOUWuw44x74DC6ZCa4zljPEW7FwLXh-RX7vePPvfGmNSo4s9DoOe0K-jqgQ0goHkMqPVDu2DjzGgVavgRh1eFQO19ayWautZbT0rqFRekEM_3_vX3YjmM_IhNgO_dwDmLzcOg4p9NtajcQH7pIx3X_W_ASM0j_s</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Zhang, Siyuan</creator><creator>Chong, Mark</creator><creator>Lau, Bernard Puang Huh</creator><creator>Ng, Yau Hong</creator><creator>Wang, Xinyu</creator><creator>Chua, Weiliang</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7622-3388</orcidid><orcidid>https://orcid.org/0000-0001-9648-0237</orcidid></search><sort><creationdate>20210701</creationdate><title>Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?</title><author>Zhang, Siyuan ; Chong, Mark ; Lau, Bernard Puang Huh ; Ng, Yau Hong ; Wang, Xinyu ; Chua, Weiliang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-1da7b5858e94a9587ed06fd08aa070974febb044ecb0f0d2efddf411470f9a543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>diabetes</topic><topic>functional outcomes</topic><topic>patient-reported outcome measures</topic><topic>range of motion</topic><topic>total knee arthroplasty</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Siyuan</creatorcontrib><creatorcontrib>Chong, Mark</creatorcontrib><creatorcontrib>Lau, Bernard Puang Huh</creatorcontrib><creatorcontrib>Ng, Yau Hong</creatorcontrib><creatorcontrib>Wang, Xinyu</creatorcontrib><creatorcontrib>Chua, Weiliang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of arthroplasty</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Siyuan</au><au>Chong, Mark</au><au>Lau, Bernard Puang Huh</au><au>Ng, Yau Hong</au><au>Wang, Xinyu</au><au>Chua, Weiliang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?</atitle><jtitle>The Journal of arthroplasty</jtitle><addtitle>J Arthroplasty</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>36</volume><issue>7</issue><spage>2486</spage><epage>2491</epage><pages>2486-2491</pages><issn>0883-5403</issn><eissn>1532-8406</eissn><abstract><![CDATA[Diabetes is one of the most common comorbidities in patients undergoing total knee arthroplasty (TKA) for osteoarthritis. However, the evidence remains unclear on how it affects patient-reported outcome measures after TKA. We reviewed prospectively collected data of 2840 patients who underwent primary unilateral TKA between 2008 and 2018, of which 716 (25.2%) had diabetes. All patients had their HbA1c measured within 1 month before surgery, and only well-controlled diabetics (HbA1c <8.0%) were allowed to proceed with surgery. Patient demographics and comorbidities were recorded, and multiple regression was performed to evaluate the impact of diabetes on improvements in patient-reported outcome measures (Short Form 36 (SF-36), Western Ontario and McMaster University Osteoarthritis Index (WOMAC), Knee Society Score (KSS)) and knee range of motion (ROM). Compared with nondiabetics, patients with diabetes were more likely to possess a higher body mass index (P-value <.001), more comorbidities (P-value <.001), and poorer preoperative SF-36 Physical Component Summary (PCS) (P-value <.001), WOMAC (P-value = .002), KSS-function (P-value <.001), and knee ROM (P-value <.001). Multiple regression showed that diabetic patients experienced marginally poorer improvements in KSS-knee (−1.22 points, P-value = .025) and knee ROM (−1.67°, P-value = .013) than nondiabetics. However, there were no significant differences in improvements for SF-36 PCS (P-value = .163), Mental Component Summary (P-value = .954), WOMAC (P-value = .815), and KSS-function (P-value = .866). Patients with well-controlled diabetes (HbA1c <8.0%) can expect similar improvements in general health and osteoarthritis outcomes (SF-36 PCS and Mental Component Summary, WOMAC, and KSS-function) compared with nondiabetics after TKA. Despite having marginally poorer improvements in knee-specific outcomes (KSS-knee and knee ROM), these differences are unlikely to be clinically significant.]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33775468</pmid><doi>10.1016/j.arth.2021.02.070</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-7622-3388</orcidid><orcidid>https://orcid.org/0000-0001-9648-0237</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0883-5403
ispartof The Journal of arthroplasty, 2021-07, Vol.36 (7), p.2486-2491
issn 0883-5403
1532-8406
language eng
recordid cdi_proquest_miscellaneous_2506510848
source ScienceDirect Freedom Collection
subjects diabetes
functional outcomes
patient-reported outcome measures
range of motion
total knee arthroplasty
title Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T23%3A47%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Do%20Patients%20With%20Diabetes%20Have%20Poorer%20Improvements%20in%20Patient-Reported%20Outcomes%20After%20Total%20Knee%20Arthroplasty?&rft.jtitle=The%20Journal%20of%20arthroplasty&rft.au=Zhang,%20Siyuan&rft.date=2021-07-01&rft.volume=36&rft.issue=7&rft.spage=2486&rft.epage=2491&rft.pages=2486-2491&rft.issn=0883-5403&rft.eissn=1532-8406&rft_id=info:doi/10.1016/j.arth.2021.02.070&rft_dat=%3Cproquest_cross%3E2506510848%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-1da7b5858e94a9587ed06fd08aa070974febb044ecb0f0d2efddf411470f9a543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2506510848&rft_id=info:pmid/33775468&rfr_iscdi=true